ASX Health Winners March A rebound Aussie biotech sector is on the radar of Asian investors - Stockhead
| EPN Stock | 0.02 0.00 0.00% |
Slightly above 56% of Epsilon Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Epsilon Healthcare stock suggests that many investors are alarmed at this time. Epsilon Healthcare's investing sentiment can be driven by a variety of factors including economic data, Epsilon Healthcare's earnings reports, geopolitical events, and overall market trends.
Epsilon |
ASX Health Winners March A rebound Aussie biotech sector is on the radar of Asian investors Stockhead
Read at news.google.com
 |
Epsilon Healthcare Fundamental Analysis
We analyze Epsilon Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epsilon Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epsilon Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Epsilon Healthcare is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Epsilon Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Epsilon Healthcare stock to make a market-neutral strategy. Peer analysis of Epsilon Healthcare could also be used in its relative valuation, which is a method of valuing Epsilon Healthcare by comparing valuation metrics with similar companies.
Peers
Epsilon Healthcare Related Equities
| ATM | Aneka Tambang | 4.65 | ||||
| BHP | BHP Group | 1.25 | ||||
| RIO | Rio Tinto | 0.94 | ||||
| CBA | Commonwealth Bank | 0.64 | ||||
| COL | Coles | 0.32 | ||||
| WES | Wesfarmers | 0.24 | ||||
| WOW | Woolworths | 0.56 | ||||
| ALD | Ampol | 1.52 |
Additional Tools for Epsilon Stock Analysis
When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.